(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

C30H41N9O3 — CID 162281572

IUPAC(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol
SMILESCC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C1CC(CCc2nc3ccc(C4(CN)CC4)cc3[nH]2)C1
InChIInChI=1S/C30H41N9O3/c1-16(2)38(12-22-25(40)26(41)29(42-22)39-15-35-24-27(32)33-14-34-28(24)39)19-9-17(10-19)3-6-23-36-20-5-4-18(11-21(20)37-23)30(13-31)7-8-30/h4-5,11,14-17,19,22,25-26,29,40-41H,3,6-10,12-13,31H2,1-2H3,(H,36,37)(H2,32,33,34)/t17?,19?,22-,25-,26-,29-/m1/s1
InChIKeyFTPZIOVOHSLFAJ-XKHGBIBOSA-N
MW575.72 g/mol
LogP2.02
Rot. Bonds10

About (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol (PubChem CID 162281572) has the molecular formula C30H41N9O3 and a molecular weight of 575.72 g/mol. Its IUPAC name is (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol.

Molecular Properties

Compound Name(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol
PubChem CID162281572
Molecular FormulaC30H41N9O3
Molecular Weight575.72 g/mol
Exact Mass575.33
IUPAC Name(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol
SMILESCC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C1CC(CCc2nc3ccc(C4(CN)CC4)cc3[nH]2)C1
InChIInChI=1S/C30H41N9O3/c1-16(2)38(12-22-25(40)26(41)29(42-22)39-15-35-24-27(32)33-14-34-28(24)39)19-9-17(10-19)3-6-23-36-20-5-4-18(11-21(20)37-23)30(13-31)7-8-30/h4-5,11,14-17,19,22,25-26,29,40-41H,3,6-10,12-13,31H2,1-2H3,(H,36,37)(H2,32,33,34)/t17?,19?,22-,25-,26-,29-/m1/s1
InChIKeyFTPZIOVOHSLFAJ-XKHGBIBOSA-N
XLogP2.02
TPSA177.25 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500575.72
LogP ≤ 52.02
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Analyze (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol?
The IUPAC name of (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol (CID 162281572) is (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol.
What is the SMILES notation for (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol?
The canonical SMILES for (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol is CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C1CC(CCc2nc3ccc(C4(CN)CC4)cc3[nH]2)C1.
What is the InChIKey of (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol?
The InChIKey is FTPZIOVOHSLFAJ-XKHGBIBOSA-N. The full InChI is InChI=1S/C30H41N9O3/c1-16(2)38(12-22-25(40)26(41)29(42-22)39-15-35-24-27(32)33-14-34-28(24)39)19-9-17(10-19)3-6-23-36-20-5-4-18(11-21(20)37-23)30(13-31)7-8-30/h4-5,11,14-17,19,22,25-26,29,40-41H,3,6-10,12-13,31H2,1-2H3,(H,36,37)(H2,32,33,34)/t17?,19?,22-,25-,26-,29-/m1/s1.
What are the key properties of (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol?
(2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol has a molecular weight of 575.72 g/mol, XLogP of 2.02, 10 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4R,5R)-2-[[[3-[2-[6-[1-(aminomethyl)cyclopropyl]-1H-benzimidazol-2-yl]ethyl]cyclobutyl]-propan-2-ylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol is sourced from PubChem (CID 162281572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).